Early-onset atherosclerosis in a patient with Tangier disease: Not all that is gold glitters

Data de publicação:

Autores da FMUP

  • Ricardo Manuel Alves Monteiro Fontes De Carvalho

    Autor

Participantes de fora da FMUP

  • Silva, G
  • Brandao, M
  • Rocha, M
  • Ferreira, W
  • Silva, M

Unidades de investigação

Abstract

[No abstract available]

Dados da publicação

ISSN/ISSNe:
0022-9032, 1897-4279

Kardiologia Polska  Via Medica

Tipo:
Editorial Material
Páginas:
421-422
Link para outro recurso:
www.scopus.com

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Atherosclerosis; Gold; Humans; Patients; Tangier Disease; cholesterol; high density lipoprotein cholesterol; triacylglycerol; gold; ABCA1 gene; adult; aortic atherosclerosis; aortic valve calcification; arthralgia; Article; cardiovascular magnetic resonance; case report; cholesterol blood level; clinical article; clinical outcome; computed tomographic angiography; coronary angiography; coronary artery disease; deterioration; disease course; dyspnea; facial nerve paralysis; family history; fatigue; female; follow up; gene; genetic screening; genetic variability; heterozygote; human; hypertension; medical history; motor dysfunction; neurologic examination; paresthesia; percutaneous coronary intervention; physical examination; smoking; Tangier disease; transcatheter aortic valve implantation; transthoracic echocardiography; triacylglycerol blood level; xanthoma; atherosclerosis; patient; Tangier disease

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846

Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes

Estudo Observacional Académico (F-CHECK) . Sanofi . 2022

The Impact of Obesity on Cardiac Function and Morphology in Aortic Stenosis

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (Obesity) . 2020

Suboptimal control of cardiovascular risk factors in myocardial infarction survivors

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (myocard) . 2020

Modeling Aortic Stenosis progression: impact on follow-up, treatment, and survival

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after ablation

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Flow-status in severe aortic stenosis for percutaneous valve implantation: Should we follow the flow?

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Cardiovascular Impact of Metabolic Syndrome: From Mechanisms to New Treatment Targets

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação